TD2 to Present at the Upcoming 4th Annual Tumor Models in Boston

July 15, 2016

TD2’s VP of Nonclinical Operations, Paul Gonzales, will be presenting at the upcoming 4th Annual Tumor Models – Boston (www.tumor-models.com) on Wednesday, July 20th.  The topic of the presentation is The Role of the Gut Microbiome on the Anti-Tumor Response of Immune Checkpoint Inhibitors in a Syngeneic Murine Model of HPV-Associated Cancer.

Contact us if you’re interested in a copy of the presentation.

Lost in Translation: Detection of mRNA by Flow Cytometry

By Rubina Pal PhD, Flow Cytometry Scientist

Read more +

Using Flow Cytometry to Characterize Myeloid Derived Suppressor Cells (MDSC)

By Darcey L. Clark, MS DABT, Senior Biotechnology Professional

Read more +

Measuring Innate Immune/Phagocytic Cell Function by Flow Cytometry

By Darcey L. Clark, MS DABT, Senior Biotechnology Professional

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.